`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`ACRUX DDS PTY LTD. & ACRUX LIMITED
`
`Petitioners,
`
`V.
`
`KAKEN PHARMACEUTICAL CO., LTD.
`Patent Owner
`
`Case: IPR2017-00190
`
`U.S. Patent No. 7,214,506
`
`PATENT OWNER’S POWER OF ATTORNEY
`
`
`
`Pursuant to 37 C.F.R. § 42.10(b), Patent Owner Kaken Pharmaceutical C0,,
`
`Ltd. appoints the practitioners associated with Finnegan, Henderson, Farabow,
`
`Garrett & Dunner, LLP (Customer Number 22,852), including the following lead
`
`and back-up counsel as its attorneys to transact all business in the U.S. Patent and
`
`Trademark Office associated with the above-captioned inter partes review of U.S.
`
`Patent 7,214,506:
`
`Lead Counsel: John D. Livingstone (Reg. No. 59,613), Tel: 404-653-6400
`
`Back-up Counsel: Naoki Yoshida (Reg. No. 48,108), Tel: 202-408-4000
`
`The individual signing below has the authority to execute this document on
`
`behalf of Patent Owner Kaken Pharmaceutical Co., Ltd.
`
`By:
`
`Tetsuo Onuma
`
`President and Representative Director
`
`Date:
`
`22ce474i0.€V (3 »
`
`0-2-9’ 5
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned certifies that a copy of the foregoing Patent Owner’s
`
`Power of Attorney was served electronically via email on December 12, 2016, in
`
`its entirety on the following:
`
`E. Anthony Figg
`efigg@rothwellfigg.com
`Rothwell, Figg, Ernst & Manbeck, P.C.
`607 14th Street, N.W., Suite 800
`Washington, DC 20005
`
`Aydin H. Harston
`aharston@rothwellfigg.com
`Rothwell, Figg, Ernst & Manbeck, P.C.
`607 14th Street, N.W., Suite 800
`Washington, DC 20005
`
`
`By: / John D. Livingstone /
`
`John D. Livingstone
`Reg. No. 59,613
`
`
`
`3